Updated Apr 15, 2026
Scaling Systems in Life Science: From Lab Bench to Commercial Launch
In life sciences, the biggest risk isn’t the science, it’s the inability to scale. Delaying systems creates compliance gaps, launch delays, and lost v...
WHITE PAPERS
Explore implementation insights, compliance guidance, and operational playbooks for life sciences organizations.
Tags
4 matching white papers
Read white paper
Updated Apr 15, 2026
Navigating the CDMO Landscape: An ERP-centric guide for modern drug...
The CDMO market is shifting from capacity to capability. Sponsors now expect partners who can reduce risk, move faster, and deliver with precision. A...
Updated Apr 15, 2026
GROSS-TO-NET (GTN) IN GENERICS: When Netsuite Is And Is Not A Good F...
Gross-to-Net (GTN) is one of the most underestimated risks in generic pharmaceutical finance. For emerging and mid-market generics companies, the ques...
Updated Apr 15, 2026
Executing at Scale in Nutraceutical Manufacturing: An ERP Implementa...
Growth in nutraceutical manufacturing is exposing what’s broken. More SKUs, tighter margins, and rising compliance demands mean execution matters more...